Flibanserin Hydrochloride
-
Post Date:
Jan 12,2019
-
Expiry Date:
Jan 12,2020
-
Detailed Description:
Cas No. :147359-76-0
Quantity: 500Kilograms
Product Name: Flibanserin Hydrochloride
Chemical Formula: C20H22ClF3N4O
Molecular Weight: 426.86
CAS:147359-76-0
Character: white powder
Purity (HPLC): 99.5%
Flibanserin (INN, USAN) (developmental code name BIMT-17; proposed trade names Girosa and Addyi) is a drug that is being studied as a non-hormonal treatment for pre-menopausal women with hypoactive sexual desire disorder (HSDD). Development by Boehringer Ingelheim was halted in October 2010 following a negative evaluation by the U.S. Food and Drug Administration. The rights to the drug were then transferred to Sprout Pharmaceuticals, which is continuing the drug development process. On June 4, 2015, the panel to the FDA recommended approval of the drug by 18–6.
-
CAS Registry Number:
147359-76-0
-
Synonyms:
;2H-Benzimidazol-2-one,1,3-dihydro-1-[2-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]ethyl]-,monohydrochloride;Flibanserin hydrochloride;
-
Molecular Formula:
C20H21F3N4O·ClH
-
Molecular Structure:
-
Company:
Wuhan Benjamin Pharmaceutical Chemical Co.,Ltd
[ China ]
-
Contact:
Miss Wang
-
Tel:
027-50661278
-
Fax:
027-87569548
-
Email:
sales03@benjaminpharmchem.com
Inquiry